The IPO World: From Africa’s Dangote Refinery to SpaceX and Soon Anthropic — Are IPOs Really Worth It?
Introduction: A New Era of IPOs
2026 has brought a strange moment in global capital markets. Three very different companies — an African refinery, a space exploration firm, and an AI safety lab — have either gone public or are about to, with combined valuations exceeding $4 trillion. Dangote Refinery is seeking a listing in Lagos at a valuation of roughly $47 billion. SpaceX has confidentially filed for what could be a $1.75 trillion IPO in New York. And Anthropic is reportedly heading toward a $2 trillion offering that could surpass SpaceX as the largest IPO in history.
But these IPOs mean far more than numbers. They raise a fundamental question: in an era of abundant private capital, mature secondary markets, and founders who can stay private indefinitely, what irreplaceable value does an IPO actually offer?
Dangote Refinery: Africa’s Industrial Ambition and the Valuation Question
The Dangote Refinery IPO is the most ambitious attempt in the history of African capital markets. At 525 naira per share, with a minimum subscription of just 10 shares — about $4 — Dangote’s goal is to make 10 million Africans part-owners of the continent’s largest refinery.
The financial turnaround has been striking: from a full-year loss of $476 million in 2025 to a net profit of $1.82 billion in the first half of 2026 alone. With capacity at 700,000 barrels per day, Nigeria has become a net exporter of refined petroleum for the first time in decades.
But the valuation has sparked fierce debate. The 525 naira offer price implies a valuation of $47 billion to $50 billion — an enterprise value-to-EBITDA multiple of roughly 18 times, far above global refining peers: Marathon Petroleum trades at about 9 times, Reliance Industries at about 10.5 times, and Sinopec at about 8.5 times. One fund manager’s comment has been widely quoted: “This feels like buying a Rolls-Royce at the price of a Gulfstream.”
Supporters argue that Dangote Refinery is not an ordinary refinery. It is a strategic asset — Africa’s only world-class refining facility, with foreign-exchange earnings, pricing power in the domestic market, and the ability to transform Nigeria from a petroleum importer into an exporter. Its scarcity — with only 3.3% free float after listing — may support a premium.
Critics point to three risks. First, H1 2026 profitability may have benefited from abnormally high refining margins caused by geopolitical crises — conditions that will not last. Second, the efficiency gains from ramping up capacity are one-time and cannot be repeated. Third, tax incentives may expire in 2028, potentially raising the effective tax rate from 13.6% to 25% and eroding about 13% of annualized profit.
The deeper issue is this: investors are paying for future capacity, not current capacity. Dangote plans to double capacity to 1.4 million barrels per day, requiring an additional $14.3 billion in investment. The financing and execution risks of that expansion fall entirely on IPO investors.
SpaceX: Musk’s “Everything Empire” and Single-Business Dependence
SpaceX’s IPO could be the largest stock offering in human history. The company is reportedly seeking over $50 billion in funding at a valuation of about $1.75 trillion, which would easily surpass Saudi Aramco’s $29.4 billion record set in 2019.
What supports that valuation is Starlink — the satellite internet business with 9 million users and the only defensible revenue engine SpaceX has. In 2025, SpaceX reportedly generated about $8 billion in profit on revenue of roughly $15 billion to $16 billion. Starlink accounts for the vast majority of that profit.
But SpaceX’s governance structure raises fundamental concerns. Musk simultaneously leads Tesla, Neuralink, The Boring Company, xAI, and X (the social media platform), and SpaceX’s charter explicitly waives the expectation to “seek opportunities for SpaceX first.” This “key person risk” is unprecedented for a company valued at over $1 trillion.
Morningstar still gives SpaceX an “exemplary” capital allocation rating, citing management’s “track record of pursuing bold initiatives that initially met investor skepticism but ultimately proved strategically and financially successful.” But that trust is essentially trust in Musk personally, not in institutional governance.
One analyst summarized the contradiction: “Investors can use sum-of-the-parts valuation, but like Tesla, SpaceX’s valuation may swing wildly based on how much the public believes in Musk’s vision.”
Anthropic: The “Doomsday IPO” of a Safety Lab
Anthropic’s IPO may be the most philosophically tense of the three.
The company was founded with an AI safety mission, and CEO Dario Amodei has put his own “probability of doom” (p(doom)) at between 10% and 25%. Evan Hubinger, who leads the company’s Alignment Science team, said publicly: “We really do earnestly believe AI could kill all humans! I personally think it is >10% within the next decade.”
One researcher wrote in an internal post: “I would burn my equity to the ground in a heartbeat for a 1% higher chance we make it out of this situation alive. I promise you, we are actually just fucking scared, it’s not galaxy-brained marketing.”
And now that company is about to go public at a $2 trillion valuation.
Anthropic’s annualized revenue run rate surged from $500 million in September 2025 to $65 billion in August 2026 — a 130-fold increase in less than a year. Investors are discussing a valuation of about $2 trillion, roughly 30 times current annualized revenue.
But that 30x multiple rests on an unresolved contradiction: the company publicly admits it has no plan to solve alignment, yet asks the public to buy its technology at a historic valuation.
Anthropic’s IPO prospectus will, for the first time, list “public backlash against AI” as a risk factor. Gallup polling shows that 70% of Americans oppose building AI data centers in their communities, with nearly half saying they are “strongly opposed.” Politically, both parties are tightening regulation of data centers.
This creates a peculiar situation: the AI boom driving Anthropic’s valuation is also the biggest risk its IPO faces.
The IPO Paradox: Is the Public Market a Punishment or a Redemption?
Across these three cases, we see a common tension: an IPO is both an endpoint and a starting point.
For Dangote, the IPO is a test of Africa’s capital market capacity — whether a Nigerian saver can, through this mechanism, own part of Africa’s largest industrial asset. But Dangote’s valuation depends on mid-cycle assumptions that may not hold once conditions normalize.
For SpaceX, the IPO is a public test of “Musk economics” — whether the market will pay $1.75 trillion for one man’s vision while accepting that he simultaneously runs more than five world-changing companies.
For Anthropic, the IPO is a public answer to a fundamental question — when a company’s founder publicly says its product has a greater than 10% chance of destroying humanity, how should the public market price it?
Public markets have something private markets lack: discipline. Private market valuations are “agreed-upon numbers” — prices that sophisticated investors agree to pay. Public market valuations are “tested numbers” — short sellers short, auditors audit, institutional investors make independent judgments.
That discipline once destroyed WeWork: a $47 billion private valuation collapsed under public market scrutiny. It also once made Microsoft and Adobe: the transparency and accountability of public markets forced them to provide clear metrics and accelerated their transitions to cloud computing and subscription models.
Are IPOs Really Worth It?
The answer depends on whom you ask and how you define “worth it.”
For employees and early investors, an IPO is a moment of liquidity — a chance to convert paper wealth into cash. Dangote’s IPO lifted Aliko Dangote’s net worth from $28.5 billion to $51.3 billion, though much of that “gain” is on paper and depends on post-listing share performance.
For the company itself, an IPO offers more than capital. It offers credibility — leverage with suppliers, customers, and partners. It offers currency — stock that can be used for acquisitions. It offers visibility — analyst coverage, media attention, index inclusion.
But an IPO also carries costs. Quarterly earnings pressure can stifle long-term investment. Disclosure requirements can expose competitive weaknesses. An influx of short-term investors can distort strategic decisions.
For society, the meaning is more complex. Dangote’s IPO is framed as “the people’s IPO” — letting ordinary Africans own part of Africa’s industrial asset. But if the valuation is too high, those retail investors buying at $4 could face falling prices after listing. The rhetoric of financial inclusion can mask the socialization of valuation risk.
Conclusion: The Final Judgment of the Public Market
The 2026 IPO wave — from Lagos to New York — represents a turning point. With abundant private capital and mature secondary markets, companies no longer choose to go public because they “need money.” They choose it because they need scrutiny.
Dangote needs to test whether African capital markets can truly operate at the largest scale. SpaceX needs to test whether one man’s vision can withstand public market examination. Anthropic needs to test whether a bet on human survival can be priced correctly.
Each of them is answering the same question: when private market valuations are no longer enough, can the public market provide a more honest answer?
Dangote’s IPO was already oversubscribed, with N1.5 trillion pouring in within six hours of opening. The market seems to be saying “yes.” But the real answer will emerge after listing — when lock-up periods expire, when employees and early investors begin cashing out, when quarterly earnings must face real numbers.
At that point, the question of whether the IPO was “worth it” will move from rhetoric to reality.
